Meanwhile, HMGA1 is used as an independent predictor in predicting the survival of patients with pancreatic cancer; it induces tumorigenesis through the PI3-K/Akt mechanism and ensures resistance to gemcitabine and anoikis 83, 105, 106. This evidence concerns the gene HMGA1 and pancreatic neoplasm.